Drug
Aic263029
Aic263029: highest development phase Phase 2, developed by AiCuris Anti-infective Cures AG. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- AiCuris Anti-infective Cures AG
Trials
| Drug | Phase | Indication |
|---|---|---|
| AIC263029 NCT07503561 | Phase 2 | BK Virus Infection |
Latest
No recent events.
Follow Aic263029 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.